# Stage 3' — Verification Re-Review

(Reduced panel: EIC + Editorial Synthesizer, per re-review mode protocol; Round-1 Reviewer Configuration Cards carried forward for yardstick continuity.)

## R&R Traceability Matrix

| # | Roadmap item | Author's claim | Verified? | Note |
|---|---|---|---|---|
| 1 | DA-CRITICAL resource-efficiency measurement | Added §3.5 parameter-count comparison; softened claim throughout | **VERIFIED** | Checked §3.5 exists, math is shown and disclosed as estimate; Abstract/§4.4/Conclusion all consistently softened, not just one section — a common revision failure mode (fixing one section, leaving contradictory claims elsewhere) did not occur here |
| 2 | ResNet-50 confound moved to Results | §3.4 expanded, §4.1 caveat added | **VERIFIED** | Confound now stated in both the baseline description (§3.4) and directly beside the comparison table (§4.1), not buried only in §5 |
| 3 | Significance test / soften language | Caveat added, "outperforming" language changed | **VERIFIED** | Grep-checked: "outperforming" no longer appears asserted as fact; Abstract, §4.1, and Conclusion all now say "directional" |
| 4 | 3-class vs 4-class clinical clarification | Sentence added to §2.2 | **VERIFIED** | Present, clinically substantive (screening vs. discrimination-only framing) |
| 5 | Preprocessing citation currency | Disclosed as gap in §3.2 | **VERIFIED (disclosed, not resolved)** | Acceptable per roadmap wording ("or note explicitly that no more recent literature was found") — author chose disclosure over a new search, which was an explicitly offered option |
| 6 | Technical-note reframing | Not applied, flagged to user | **VERIFIED as intentionally deferred** | Matches Response-to-Reviewers' own statement; this was advisory (P2, "user's call") in the original roadmap, so non-action is a valid response, not a dropped item |

## New issues introduced by the revision

None identified. Spot-checked the new §3.5 parameter-count arithmetic (1280×720+720 + 720×360+360 + 360×360+360 + 360×180+180 + 180×4+4 = 1,377,544; +5,288,548 base ≈ 6,666,092) — recomputed independently and confirms the paper's stated ~6.67M figure.

## Residual issues (not blocking, carried to Acknowledged Limitations)

- The paper now honestly reports a *weaker* headline claim than Round 1 (directional, not significant; partial not full resource-efficiency evidence). This is the correct outcome of addressing DA-CRITICAL honestly rather than a revision failure — flagging so the user understands this is expected, not a regression.
- Statistical test and inference-time measurement remain unresolved in substance (only in disclosure) — appropriately deferred to Future Work since they require re-running the training pipeline, which is out of scope for this revision per the established Stage 2.5 override.

## Decision: **MINOR REVISION → effectively ACCEPT-track**

All P0/P1 items verified addressed with real content changes (not just cosmetic caveats — e.g., §3.5 is a genuine new measurement, not a hedge sentence). No new DA-CRITICAL or MAJOR issues introduced by the revision. Remaining gaps are honestly disclosed limitations requiring future experimental work outside this pipeline run's scope, which is the correct outcome given the Stage 2.5 override on Failure Modes 3/6 (no code execution in this pass).

**No Stage 4' (re-revision round) required.** Proceeding to Stage 4.5 Final Integrity.
